Role of CTLA-4 blockade and dacarbazine therapy following anti-PD-1 resistance in melanoma
Abstract Many patients with advanced melanoma eventually stop responding to PD-1 immunotherapy, and effective treatments are limited. Recent studies suggest that older chemotherapy drugs such as dacarbazine and temozolomide may work better after prior PD-1 therapy and can stimulate the immune system...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer
2026-03-01
|
| Edice: | Discover Oncology |
| Témata: | |
| On-line přístup: | https://doi.org/10.1007/s12672-026-04816-5 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|